Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LDHA | P00338 | 3/20 | 0.48 |
| ▸ | LDHB | P07195 | 3/20 | 0.48 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.48 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | ACHE | P22303 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | GRM1 | Q13255 | 2/20 | 0.40 |
| ▸ | AKR1C4 | P17516 | 2/20 | 0.39 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.39 |
| ▸ | AKR1C2 | P52895 | 2/20 | 0.39 |
| ▸ | AKR1C1 | Q04828 | 2/20 | 0.39 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11561454 | 0.88 | HMGB1 (0.46) | LDHALDHBHMGB1CXCL12ALDH1A1 | |
| SCHEMBL27777852 | 0.85 | HMGB1 (0.55) | LDHALDHBHMGB1CXCL12ALDH1A1 | |
| SCHEMBL10785106 | 0.83 | LDHA (0.48) | LDHALDHBHMGB1CXCL12ALDH1A1 | |
| SCHEMBL29031971 | 0.83 | CYP3A4 (0.50) | LDHALDHBHMGB1CXCL12ALDH1A1 | |
| SCHEMBL4641265 | 0.83 | LDHA (0.48) | LDHALDHBHMGB1CXCL12ALDH1A1 | |
| SCHEMBL14989265 | 0.83 | KDM4E (0.44) | LDHALDHBHMGB1CXCL12ALDH1A1 | |
| SCHEMBL6904405 | 0.83 | KDM4E (0.45) | LDHALDHBHMGB1CXCL12ALDH1A1 | |
| SCHEMBL8830205 | 0.83 | LDHA (0.52) | LDHALDHBHMGB1CXCL12ALDH1A1 | |
| SCHEMBL31315038 | 0.83 | HMGB1 (0.52) | LDHALDHBHMGB1CXCL12ALDH1A1 | |
| SCHEMBL8830153 | 0.83 | HMGB1 (0.52) | LDHALDHBHMGB1CXCL12ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0132717-B1 | HEAT-SENSITIVE RECORD MATERIAL | KANZAKI PAPER MANUFACTURING COMPANY LIMITED (JP) | 1987-04-22 | — | — | EP | claimed |
| US-20080132689-A1 | Complexing using an ortho carboxy acetal; biodrug delivery | ROCHE MADISON INC | 2008-06-05 | — | — | US | disclosed |
| US-7348453-B2 | Labile linkage for compound delivery to a cell | MIRUS BIO CORPORATION (US) | 2008-03-25 | — | — | US | disclosed |
| WO-2005026253-A2 | LABILE LINKAGE FOR COMPOUND DELIVERY TO A CELL | MIRUS BIO CORPORATION (US) | 2005-03-24 | — | — | WO | disclosed |
| US-20050054604-A1 | Labile linkage for compound delivery to a cell | ROCHE MADISON INC. | 2005-03-10 | — | — | US | disclosed |
| US-20030144458-A1 | Novel amphiphilic polymeric materials | UNIVERSITY OF MASSACHUSETTS, A MASSACHUSETTS CORPORATION | 2003-07-31 | — | — | US | disclosed |
| US-6521736-B2 | Can be used in development of physiologically stable, non-leaking, non-immunogenic, efficacious and safe targetable drug delivery systems e.g., for delivery of anti-HIV or anticancer drugs | UNIVERSITY OF MASSACHUSETTS | 2003-02-18 | — | — | US | disclosed |
| US-20020099164-A1 | Novel amphiphilic polymeric materials | UNIVERSITY OF MASSACHUSETTS | 2002-07-25 | — | — | US | disclosed |
| EP-0583609-A1 | Multiply-branched aliphatic-aromatic polyether esters and their preparation | EASTMAN KODAK COMPANY (US) | 1994-02-23 | — | — | EP | disclosed |
| US-5225522-A | Multiply-branched aliphatic-aromatic polyesters and method for preparing multiply-branched aliphatic-aromatic polyesters | EASTMAN KODAK COMPANY (US) | 1993-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050054604-A1 | Labile linkage for compound delivery to a cell | AADAC, PAICS, FURIN | LDHA 1567/4885LDHB 1332/4885HMGB1 885/4885 |
| US-20080132689-A1 | Complexing using an ortho carboxy acetal; biodrug delivery | CEL, PAICS, OGA | LDHA 2656/4885LDHB 2273/4885HMGB1 1282/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.